Fei Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Fei Gao has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Junchi Xu
Department of Clinical Laboratory, The Fifth People’s Hospital of Suzhou
4 shared publications Huafeng Song
Department of Clinical Laboratory, The Fifth People’s Hospital of Suzhou
2 shared publicationsSufang Chen
Department of Clinical Laboratory, The Fifth People’s Hospital of Suzhou
2 shared publicationsGeng-Chao Zhu
The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, P. R. China
1 shared publicationHongyan Zhang
Department of Clinical Laboratory, Children’s Hospital of Wujiang District
1 shared publicationHui Chen
The Fifth People’s Hospital of Suzhou, Suzhou, P. R. China
1 shared publication
Latest Publications
- Open Access
- 16 October 2026
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 16, 1791097
Clinical significance and discriminatory performance of the serum KL-6 level as a biomarker for severe Chlamydia pneumoniae infection in children
Objective: To characterize the expression and evaluate the clinical utility for assessing disease severity of the serum Krebs von den Lungen-6 (KL-6) level in children with mild and severe acute Chlamydia pneumoniae ( C. pneumoniae ) infection. Methods: A total of 68 hospitalized children with acute lower respiratory tract infection caused by C. pneumoniae (48 mild cases and 20 severe cases) who were admitted to Children’s Hospital of Wujiang District from May 2024 to April 2025 were enrolled, with 19 healthy children included in the control group. Serum KL-6 levels, C. pneumoniae -IgM levels, and routine laboratory indicators were measured. The correlation between the KL-6 level and clinical features was analyzed, and discriminatory performance of the KL-6 level for identifying severe C. pneumoniae infection was assessed using ROC curves. Results: Serum KL-6 levels were significantly higher in the severe group than in the mild group [303.00 (227.75, 328.25) U/mL vs. 146.50 (133.50, 164.25) U/mL, P < 0.001]. Binary logistic regression analysis indicated that KL-6 was independently associated with severe C. pneumoniae infection in children (P < 0.001), and the area under the curve (AUC) for differentiating severe infection from mild infection was 0.951 (95%CI=0.880-0.997, PC. pneumoniae -IgM levels but not with other indicators. Conclusion: The serum KL-6 level can effectively reflect the degree of pulmonary parenchymal injury in children with C. pneumoniae infection and can serve as an independent biomarker for severe C. pneumoniae infection. It demonstrates high discriminatory ability for identifying severe cases and may serve as an auxiliary biomarker for assessing pulmonary parenchymal injury.
- 16 October 2026
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 16, 1791097
Open AccessClinical significance and discriminatory performance of the serum KL-6 level as a biomarker for severe Chlamydia pneumoniae infection in children
Objective: To characterize the expression and evaluate the clinical utility for assessing disease severity of the serum Krebs von den Lungen-6 (KL-6) level in children with mild and severe acute Chlamydia pneumoniae ( C. pneumoniae ) infection. Methods: A total of 68 hospitalized children with acute lower respiratory tract infection caused by C. pneumoniae (48 mild cases and 20 severe cases) who were admitted to Children’s Hospital of Wujiang District from May 2024 to April 2025 were enrolled, with 19 healthy children included in the control group. Serum KL-6 levels, C. pneumoniae -IgM levels, and routine laboratory indicators were measured. The correlation between the KL-6 level and clinical features was analyzed, and discriminatory performance of the KL-6 level for identifying severe C. pneumoniae infection was assessed using ROC curves. Results: Serum KL-6 levels were significantly higher in the severe group than in the mild group [303.00 (227.75, 328.25) U/mL vs. 146.50 (133.50, 164.25) U/mL, P < 0.001]. Binary logistic regression analysis indicated that KL-6 was independently associated with severe C. pneumoniae infection in children (P < 0.001), and the area under the curve (AUC) for differentiating severe infection from mild infection was 0.951 (95%CI=0.880-0.997, PC. pneumoniae -IgM levels but not with other indicators. Conclusion: The serum KL-6 level can effectively reflect the degree of pulmonary parenchymal injury in children with C. pneumoniae infection and can serve as an independent biomarker for severe C. pneumoniae infection. It demonstrates high discriminatory ability for identifying severe cases and may serve as an auxiliary biomarker for assessing pulmonary parenchymal injury.
- Open Access
- 9 July 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1873405
Immunotherapy for tuberculosis: emerging modalities, cross-disciplinary innovations, and roadmaps for drug-resistant disease
Rationale: The emergence of multidrug-resistant tuberculosis (MDR-TB) and limitations of current antibiotic therapies highlight the urgent need for novel treatment strategies. While immunotherapy has revolutionized cancer treatment, its potential in TB remains underexplored, with existing reviews focusing narrowly on vaccines and phage therapy. A comprehensive synthesis of TB immunotherapy advancements is critical to guide clinical translation. Content: Tuberculosis (TB) has been recognized as one of the earliest diseases treated with immunotherapy. The BCG vaccine played a crucial role in controlling TB epidemics for a long period. However, progress in TB immunotherapy stagnated due to the attenuation of BCG strains and the long-standing neglect in TB immunology research. In recent years, advances in TB and immunology research, including novel immunological theories such as trained immunity, alongside breakthroughs in various immunotherapies for cancer treatment, have provided new perspectives for TB treatment. This review summarizes the immune response to TB, including roles of macrophages, T cells, and nonclassical immune cells. It evaluates progress in cell therapy, antibody therapy, microbial therapy, vaccines, and cytokine therapy. Clinical trials, mechanisms, and challenges (e.g., immune exhaustion, antigen heterogeneity) of TB immunotherapy are analyzed, drawing parallels with cancer immunotherapy. Conclusions: Immunotherapy offers multifaceted strategies to overcome Mtb drug resistance and reduce side effects. Key directions include identifying novel antigens, optimizing immune checkpoint modulation, and combining therapies. Advances in single-cell sequencing and bioengineering will accelerate development, making immunotherapy a promising adjunct to conventional TB treatment.
- 9 July 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1873405
Open AccessImmunotherapy for tuberculosis: emerging modalities, cross-disciplinary innovations, and roadmaps for drug-resistant disease
Rationale: The emergence of multidrug-resistant tuberculosis (MDR-TB) and limitations of current antibiotic therapies highlight the urgent need for novel treatment strategies. While immunotherapy has revolutionized cancer treatment, its potential in TB remains underexplored, with existing reviews focusing narrowly on vaccines and phage therapy. A comprehensive synthesis of TB immunotherapy advancements is critical to guide clinical translation. Content: Tuberculosis (TB) has been recognized as one of the earliest diseases treated with immunotherapy. The BCG vaccine played a crucial role in controlling TB epidemics for a long period. However, progress in TB immunotherapy stagnated due to the attenuation of BCG strains and the long-standing neglect in TB immunology research. In recent years, advances in TB and immunology research, including novel immunological theories such as trained immunity, alongside breakthroughs in various immunotherapies for cancer treatment, have provided new perspectives for TB treatment. This review summarizes the immune response to TB, including roles of macrophages, T cells, and nonclassical immune cells. It evaluates progress in cell therapy, antibody therapy, microbial therapy, vaccines, and cytokine therapy. Clinical trials, mechanisms, and challenges (e.g., immune exhaustion, antigen heterogeneity) of TB immunotherapy are analyzed, drawing parallels with cancer immunotherapy. Conclusions: Immunotherapy offers multifaceted strategies to overcome Mtb drug resistance and reduce side effects. Key directions include identifying novel antigens, optimizing immune checkpoint modulation, and combining therapies. Advances in single-cell sequencing and bioengineering will accelerate development, making immunotherapy a promising adjunct to conventional TB treatment.
- Open Access
- 22 November 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1477646
Altered mitochondrial mass and low mitochondrial membrane potential of immune cells in patients with HBV infection and correlation with liver inflammation
Introduction: Mitochondrial membrane potential (MMP) and mitochondrial mass (MM) affect mitochondrial function and lymphocyte activation, but few studies on HBV infection exist. This study aimed to investigate the regulatory mechanism of mitochondrial dysfunction during HBV infection and its clinical significance by analyzing the alterations of MM and MMPlow in peripheral blood immune cells.Methods: The study enrolled 90 participants, including healthy volunteers(HC) and patients with HBV infection, HBV patients were divided into chronic hepatitis B patients (CHB) and liver cirrhosis (LC) according to the study, and CHB was also divided into an inflammation group and a non-inflammation group. Flow cytometry was used to analyze the changes of MM and MMPlow in peripheral blood immune cells. These analyses were correlated with the presence of CHB and LC and indexes related to liver inflammation.Results: The study revealed significant variations in the percentage of MMPlow and MM of CD8+T cells associated with the progression of the disease. The MMPlow percentage of CD8+T cells in the LC group exhibited a notable decrease compared to the HC group and CHB groups. Moreover, MMPlow of CD8+T cells demonstrated potential in distinguishing CHB and LC (AUC=0.7341, P=0.0032). Furthermore, in exploring the link between mitochondrial function of immune cells and liver inflammation, the study found a negative correlation between the MMPlow ratio of CD4+T and CD8+T cells and AST (p=0.0039 and P=0.0070, r=-0.4405 and r=-0.4146), while the MM of CD8+T cells displayed a positive correlation with AST (p=0.0013, r=0.4865). In CHB patients with normal ALT but liver inflammation detected on B-scan ultrasonography, a significant decrease was observed in the MMPlow percentage of CD8+T (66.13 ± 14.27), CD56+NK(57.77 ± 17.40) and CD4-CD8-T (61.98 ± 15.98) cells. Furthermore, it was also found that the percentage of MMPlow in CD4-CD8-T cells could serve as an indicator for early liver inflammation and injury (AUC=0.8408, P=0.0052).Discussion: In this study, we conducted a systematic analysis of the percentage of lymphocyte MMPlow and MM in various stages of HBV infection. Our findings revealed a correlation between MMPlow and MM and early liver inflammation, as well as the progression of the infection. This study marked the first demonstration of the clinical diagnostic value of MMPlow and MM in HBV infection. Furthermore, this was the first study to discuss the mitochondria of lymphocytes and liver inflammation in HBV infection. It enhanced the understanding of the role of T cells in liver inflammation, and elucidated potential markers for the early detection of liver injury and clinical cirrhosis.
- 22 November 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1477646
Open AccessAltered mitochondrial mass and low mitochondrial membrane potential of immune cells in patients with HBV infection and correlation with liver inflammation
Introduction: Mitochondrial membrane potential (MMP) and mitochondrial mass (MM) affect mitochondrial function and lymphocyte activation, but few studies on HBV infection exist. This study aimed to investigate the regulatory mechanism of mitochondrial dysfunction during HBV infection and its clinical significance by analyzing the alterations of MM and MMPlow in peripheral blood immune cells.Methods: The study enrolled 90 participants, including healthy volunteers(HC) and patients with HBV infection, HBV patients were divided into chronic hepatitis B patients (CHB) and liver cirrhosis (LC) according to the study, and CHB was also divided into an inflammation group and a non-inflammation group. Flow cytometry was used to analyze the changes of MM and MMPlow in peripheral blood immune cells. These analyses were correlated with the presence of CHB and LC and indexes related to liver inflammation.Results: The study revealed significant variations in the percentage of MMPlow and MM of CD8+T cells associated with the progression of the disease. The MMPlow percentage of CD8+T cells in the LC group exhibited a notable decrease compared to the HC group and CHB groups. Moreover, MMPlow of CD8+T cells demonstrated potential in distinguishing CHB and LC (AUC=0.7341, P=0.0032). Furthermore, in exploring the link between mitochondrial function of immune cells and liver inflammation, the study found a negative correlation between the MMPlow ratio of CD4+T and CD8+T cells and AST (p=0.0039 and P=0.0070, r=-0.4405 and r=-0.4146), while the MM of CD8+T cells displayed a positive correlation with AST (p=0.0013, r=0.4865). In CHB patients with normal ALT but liver inflammation detected on B-scan ultrasonography, a significant decrease was observed in the MMPlow percentage of CD8+T (66.13 ± 14.27), CD56+NK(57.77 ± 17.40) and CD4-CD8-T (61.98 ± 15.98) cells. Furthermore, it was also found that the percentage of MMPlow in CD4-CD8-T cells could serve as an indicator for early liver inflammation and injury (AUC=0.8408, P=0.0052).Discussion: In this study, we conducted a systematic analysis of the percentage of lymphocyte MMPlow and MM in various stages of HBV infection. Our findings revealed a correlation between MMPlow and MM and early liver inflammation, as well as the progression of the infection. This study marked the first demonstration of the clinical diagnostic value of MMPlow and MM in HBV infection. Furthermore, this was the first study to discuss the mitochondria of lymphocytes and liver inflammation in HBV infection. It enhanced the understanding of the role of T cells in liver inflammation, and elucidated potential markers for the early detection of liver injury and clinical cirrhosis.
- Open Access
- 10 July 2023
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 23 (1) , 1-9
Clinical significance of B7-H3 expression in circulating CD4+CD25high T cells, CD14+ monocytes, and plasma for the progression of HIV infection
Background: B7-H3 is an important immune checkpoint molecule that plays a negative role in immune regulation. This study was aimed to explore B7-H3 expression in HIV-infected patients and its clinical significance. Methods: To explore the expression and clinical significance of B7-H3 in HIV-infected patients, we investigated the B7-H3 expression pattern and the correlation of B7-H3 expression with clinical parameters of HIV-infected patients with different levels of CD4+ T cells. To assess the role of B7-H3 in regulating the function of T cells in HIV infection, we performed a proliferation assay and T cell function test in vitro. Results: B7-H3 expression in HIV-infected patients was significantly higher than that in healthy controls. mB7-H3 expression on CD4+CD25high T cells and CD14+ monocytes increased with disease progression. mB7-H3 expression on CD4+CD25high T cells and monocytes was negatively correlated with lymphocyte count, CD4+T cell count, and positively correlated with HIV viral load in HIV-infected patients. when the number of CD4+ T cells in HIV-infected patients was ≥ 200/µL, sB7-H3 and mB7-H3 expression levels on CD4+CD25high T cells and monocytes were negatively correlated with lymphocyte count, CD4+T cell count. sB7-H3 and mB7-H3 expression on monocytes were positively correlated with HIV viral load. B7-H3 inhibited the proliferation of lymphocytes and the secretion of IFN-γ in vitro, especially the ability of CD8+ T cells to secrete IFN-γ. Conclusions: B7-H3 played an important negative regulatory role in anti-HIV infection immunity. It could be used as a potential biomarker for the progression of HIV infection and a novel target for the treatment of HIV infection.
- 10 July 2023
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 23 (1) , 1-9
Open AccessClinical significance of B7-H3 expression in circulating CD4+CD25high T cells, CD14+ monocytes, and plasma for the progression of HIV infection
Background: B7-H3 is an important immune checkpoint molecule that plays a negative role in immune regulation. This study was aimed to explore B7-H3 expression in HIV-infected patients and its clinical significance. Methods: To explore the expression and clinical significance of B7-H3 in HIV-infected patients, we investigated the B7-H3 expression pattern and the correlation of B7-H3 expression with clinical parameters of HIV-infected patients with different levels of CD4+ T cells. To assess the role of B7-H3 in regulating the function of T cells in HIV infection, we performed a proliferation assay and T cell function test in vitro. Results: B7-H3 expression in HIV-infected patients was significantly higher than that in healthy controls. mB7-H3 expression on CD4+CD25high T cells and CD14+ monocytes increased with disease progression. mB7-H3 expression on CD4+CD25high T cells and monocytes was negatively correlated with lymphocyte count, CD4+T cell count, and positively correlated with HIV viral load in HIV-infected patients. when the number of CD4+ T cells in HIV-infected patients was ≥ 200/µL, sB7-H3 and mB7-H3 expression levels on CD4+CD25high T cells and monocytes were negatively correlated with lymphocyte count, CD4+T cell count. sB7-H3 and mB7-H3 expression on monocytes were positively correlated with HIV viral load. B7-H3 inhibited the proliferation of lymphocytes and the secretion of IFN-γ in vitro, especially the ability of CD8+ T cells to secrete IFN-γ. Conclusions: B7-H3 played an important negative regulatory role in anti-HIV infection immunity. It could be used as a potential biomarker for the progression of HIV infection and a novel target for the treatment of HIV infection.
- 18 August 2021
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 35 (9) , e23947
The diagnostic value of the combination of hemoglobin, CA199, CA125, and HE4 in endometriosis
Background: We aimed to analyze the differences in the peripheral blood cells and tumor biomarkers between the patients with endometriosis and healthy people, and establish a more efficient combined diagnostic model.Methods: We retrospectively analyzed the differences in the peripheral blood cells and tumor biomarkers between the patients with endometriosis and healthy people. Binary logistic regression analysis was used to establish a combined diagnostic model. We plotted the receiver operator characteristic (ROC) curve to analyze the diagnostic efficiency of different diagnostic indexes.Results: Compared with patients in the control group, patients in the endometriosis group had significantly lower eosinophil% (p = 0.045), neutrophil (p = 0.001), lymphocyte (p < 0.001), red blood cells (RBCs) (p < 0.001), and hemoglobin (HGB) (p < 0.001), and had significantly higher monocyte% (p = 0.008), monocyte‐to‐lymphocyte ratio (MLR) (p = 0.001), platelet‐to‐lymphocyte ratio (PLR) (p < 0.001), carbohydrate antigen (CA)‐199 (p < 0.001), CA125 (p < 0.001), human epididymis protein (HE)‐4 (p < 0.001), and the risk of ovarian malignancy algorithm (ROMA) (p < 0.001). The combined diagnostic model of HGB, CA199, CA125, and HE4 was established by binary logistic regression analysis. The ROC curve showed that the combined diagnostic model reached a sensitivity of 85.4%, a specificity of 78.83%, and an area under the curve of 0.900, which was significantly higher than that of the individual index in endometriosis diagnosis.Conclusion: The combined diagnostic model of HGB, CA199, CA125, and HE4 may provide a new approach for the early non‐invasive diagnosis of endometriosis.
- 18 August 2021
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 35 (9) , e23947
The diagnostic value of the combination of hemoglobin, CA199, CA125, and HE4 in endometriosis
Background: We aimed to analyze the differences in the peripheral blood cells and tumor biomarkers between the patients with endometriosis and healthy people, and establish a more efficient combined diagnostic model.Methods: We retrospectively analyzed the differences in the peripheral blood cells and tumor biomarkers between the patients with endometriosis and healthy people. Binary logistic regression analysis was used to establish a combined diagnostic model. We plotted the receiver operator characteristic (ROC) curve to analyze the diagnostic efficiency of different diagnostic indexes.Results: Compared with patients in the control group, patients in the endometriosis group had significantly lower eosinophil% (p = 0.045), neutrophil (p = 0.001), lymphocyte (p < 0.001), red blood cells (RBCs) (p < 0.001), and hemoglobin (HGB) (p < 0.001), and had significantly higher monocyte% (p = 0.008), monocyte‐to‐lymphocyte ratio (MLR) (p = 0.001), platelet‐to‐lymphocyte ratio (PLR) (p < 0.001), carbohydrate antigen (CA)‐199 (p < 0.001), CA125 (p < 0.001), human epididymis protein (HE)‐4 (p < 0.001), and the risk of ovarian malignancy algorithm (ROMA) (p < 0.001). The combined diagnostic model of HGB, CA199, CA125, and HE4 was established by binary logistic regression analysis. The ROC curve showed that the combined diagnostic model reached a sensitivity of 85.4%, a specificity of 78.83%, and an area under the curve of 0.900, which was significantly higher than that of the individual index in endometriosis diagnosis.Conclusion: The combined diagnostic model of HGB, CA199, CA125, and HE4 may provide a new approach for the early non‐invasive diagnosis of endometriosis.